日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/03/11 | 4,533 | 4,581 | 4,482 | 4,556 | +36 | +0.8% | 418,300 |
| 2024/03/08 | 4,424 | 4,525 | 4,350 | 4,520 | +26 | +0.6% | 548,500 |
| 2024/03/07 | 4,560 | 4,605 | 4,451 | 4,494 | -72 | -1.6% | 590,700 |
| 2024/03/06 | 4,431 | 4,584 | 4,414 | 4,566 | +54 | +1.2% | 638,700 |
| 2024/03/05 | 4,645 | 4,652 | 4,484 | 4,512 | -273 | -5.7% | 954,500 |
| 2024/03/04 | 4,801 | 4,847 | 4,779 | 4,785 | -5 | -0.1% | 401,000 |
| 2024/03/01 | 4,805 | 4,940 | 4,790 | 4,790 | +20 | +0.4% | 415,500 |
| 2024/02/29 | 4,790 | 4,804 | 4,716 | 4,770 | -22 | -0.5% | 509,300 |
| 2024/02/28 | 4,794 | 4,897 | 4,781 | 4,792 | -72 | -1.5% | 571,300 |
| 2024/02/27 | 4,807 | 4,877 | 4,800 | 4,864 | +46 | +1% | 506,000 |
| 2024/02/26 | 4,860 | 4,900 | 4,801 | 4,818 | -22 | -0.5% | 922,700 |
| 2024/02/22 | 4,931 | 4,961 | 4,840 | 4,840 | -91 | -1.8% | 544,600 |
| 2024/02/21 | 4,941 | 4,955 | 4,896 | 4,931 | -19 | -0.4% | 195,200 |
| 2024/02/20 | 4,972 | 4,982 | 4,945 | 4,950 | -12 | -0.2% | 231,300 |
| 2024/02/19 | 5,049 | 5,050 | 4,946 | 4,962 | -87 | -1.7% | 251,400 |
| 2024/02/16 | 4,938 | 5,049 | 4,891 | 5,049 | +161 | +3.3% | 284,700 |
| 2024/02/15 | 4,912 | 4,922 | 4,827 | 4,888 | -44 | -0.9% | 345,900 |
| 2024/02/14 | 4,942 | 4,998 | 4,857 | 4,932 | -11 | -0.2% | 396,300 |
| 2024/02/13 | 5,100 | 5,119 | 4,917 | 4,943 | -226 | -4.4% | 896,700 |
| 2024/02/09 | 5,145 | 5,213 | 5,110 | 5,169 | +22 | +0.4% | 279,900 |
| 2024/02/08 | 5,120 | 5,170 | 5,086 | 5,147 | +37 | +0.7% | 221,600 |
| 2024/02/07 | 5,161 | 5,166 | 5,067 | 5,110 | -21 | -0.4% | 249,000 |
| 2024/02/06 | 5,225 | 5,225 | 5,117 | 5,131 | -107 | -2% | 211,400 |
| 2024/02/05 | 5,189 | 5,281 | 5,185 | 5,238 | +75 | +1.5% | 247,400 |
| 2024/02/02 | 5,182 | 5,212 | 5,160 | 5,163 | -26 | -0.5% | 195,600 |
| 2024/02/01 | 5,182 | 5,212 | 5,149 | 5,189 | -46 | -0.9% | 222,900 |
| 2024/01/31 | 5,200 | 5,238 | 5,145 | 5,235 | +1 | ±0% | 262,100 |
| 2024/01/30 | 5,252 | 5,316 | 5,224 | 5,234 | -7 | -0.1% | 354,800 |
| 2024/01/29 | 5,287 | 5,330 | 5,212 | 5,241 | -10 | -0.2% | 244,900 |
| 2024/01/26 | 5,249 | 5,298 | 5,230 | 5,251 | -17 | -0.3% | 280,900 |
| 2024/01/25 | 5,283 | 5,321 | 5,193 | 5,268 | -30 | -0.6% | 203,400 |
| 2024/01/24 | 5,216 | 5,327 | 5,207 | 5,298 | +118 | +2.3% | 358,900 |
| 2024/01/23 | 5,192 | 5,255 | 5,165 | 5,180 | +60 | +1.2% | 181,100 |
| 2024/01/22 | 5,126 | 5,145 | 5,093 | 5,120 | +19 | +0.4% | 138,900 |
| 2024/01/19 | 5,112 | 5,131 | 5,071 | 5,101 | -9 | -0.2% | 273,200 |
| 2024/01/18 | 5,087 | 5,130 | 5,084 | 5,110 | +1 | ±0% | 209,200 |
| 2024/01/17 | 5,154 | 5,177 | 5,088 | 5,109 | -48 | -0.9% | 288,800 |
| 2024/01/16 | 5,185 | 5,217 | 5,145 | 5,157 | -45 | -0.9% | 190,300 |
| 2024/01/15 | 5,286 | 5,286 | 5,177 | 5,202 | -56 | -1.1% | 216,300 |
| 2024/01/12 | 5,253 | 5,278 | 5,197 | 5,258 | +69 | +1.3% | 377,900 |
| 2024/01/11 | 5,290 | 5,290 | 5,175 | 5,189 | -51 | -1% | 375,900 |
| 2024/01/10 | 5,225 | 5,274 | 5,204 | 5,240 | -8 | -0.2% | 308,900 |
| 2024/01/09 | 5,246 | 5,269 | 5,189 | 5,248 | +56 | +1.1% | 198,600 |
| 2024/01/05 | 5,255 | 5,256 | 5,162 | 5,192 | -62 | -1.2% | 244,000 |
| 2024/01/04 | 5,066 | 5,258 | 5,031 | 5,254 | +258 | +5.2% | 435,600 |
| 2023/12/29 | 4,981 | 5,006 | 4,962 | 4,996 | +1 | ±0% | 159,700 |
| 2023/12/28 | 5,000 | 5,019 | 4,936 | 4,995 | +44 | +0.9% | 147,500 |
| 2023/12/27 | 4,875 | 4,959 | 4,875 | 4,951 | +76 | +1.6% | 181,300 |
| 2023/12/26 | 4,890 | 4,908 | 4,839 | 4,875 | -21 | -0.4% | 195,300 |
| 2023/12/25 | 4,930 | 4,941 | 4,883 | 4,896 | -10 | -0.2% | 115,900 |
301～
350
件表示中 / 3712件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 351,900円 | +8.0% | -15.3% | 3.52% | 9.88倍 | 0.96倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 住友ファーマ | 84,000円 | -11.0% | +206.6% | 0.00% | 8.34倍 | 1.97倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ツムラ | 334,000円 | +3.8% | -19.9% | 4.07% | 10.93倍 | 0.84倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| サンバイオ | 337,000円 | - | - | 0.00% | - | 156.09倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ペプチド | 168,700円 | +5.0% | +1.5% | 0.00% | 14.43倍 | 3.84倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム
